 Connection
Randall Meacham to Prostatic Neoplasms
This is a "connection" page, showing publications Randall Meacham has written about Prostatic Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.827 |
|
|
|
-
Koul HK, Kumar B, Koul S, Deb AA, Hwa JS, Maroni P, van Bokhoven A, Lucia MS, Kim FJ, Meacham RB. The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment. Drugs Today (Barc). 2010 Dec; 46(12):929-43.
Score: 0.222
-
Oberley-Deegan RE, Steffan JJ, Rove KO, Pate KM, Weaver MW, Spasojevic I, Frederick B, Raben D, Meacham RB, Crapo JD, Koul HK. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. PLoS One. 2012; 7(9):e44178.
Score: 0.063
-
Steffan JJ, Koul S, Meacham RB, Koul HK. The transcription factor SPDEF suppresses prostate tumor metastasis. J Biol Chem. 2012 Aug 24; 287(35):29968-78.
Score: 0.062
-
Koul HK, Koul S, Meacham RB. New role for an established drug? Bisphosphonates as potential anticancer agents. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):111-9.
Score: 0.059
-
Johnson TR, Koul S, Kumar B, Khandrika L, Venezia S, Maroni PD, Meacham RB, Koul HK. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol Cancer. 2010 Jun 15; 9:148.
Score: 0.054
-
Meacham RB, Scardino PT, Hoffman GS, Easley JD, Wilbanks JH, Carlton CE. The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol. 1989 Aug; 142(2 Pt 1):320-5.
Score: 0.051
-
Khandrika L, Lieberman R, Koul S, Kumar B, Maroni P, Chandhoke R, Meacham RB, Koul HK. Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1alpha levels contribute to emergence of an aggressive phenotype in prostate cancer. Oncogene. 2009 Mar 05; 28(9):1248-60.
Score: 0.049
-
Holyoak JD, Crawford ED, Meacham RB. Testosterone and the prostate: implications for the treatment of hypogonadal men. Curr Urol Rep. 2008 Nov; 9(6):500-5.
Score: 0.048
-
Johnson TR, Khandrika L, Kumar B, Venezia S, Koul S, Chandhoke R, Maroni P, Donohue R, Meacham RB, Koul HK. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer. Mol Cancer Res. 2008 Oct; 6(10):1639-48.
Score: 0.048
-
Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008 Mar 15; 68(6):1777-85.
Score: 0.046
-
Mills JN, Meacham RB. Evaluation of unexplained secondary azoospermia. J Androl. 2007 Mar-Apr; 28(2):214-5.
Score: 0.042
-
Koul HK, Maroni PD, Meacham RB, Crawford D, Koul S. p42/p44 Mitogen-activated protein kinase signal transduction pathway: a novel target for the treatment of hormone-resistant prostate cancer? Ann N Y Acad Sci. 2004 Dec; 1030:243-52.
Score: 0.037
-
Koul S, Huang M, Chaturvedi L, Meacham RB, Koul HK. p42/p44 Mitogen-activated protein kinase signal transduction pathway regulates interleukin-6 expression in PC3 cells, a line of hormone-refractory prostate cancer cells. Ann N Y Acad Sci. 2004 Dec; 1030:253-7.
Score: 0.037
-
Scardino PT, Frankel JM, Wheeler TM, Meacham RB, Hoffman GS, Seale C, Wilbanks JH, Easley J, Carlton CE. The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol. 1986 Mar; 135(3):510-6.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|